Risk factors for uterine fibroids: reduced risk associated with oral contraceptives
- PMID: 3730804
- PMCID: PMC1341047
- DOI: 10.1136/bmj.293.6543.359
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives
Erratum in
- Br Med J (Clin Res Ed) 1986 Oct 18;293(6553):1027
Abstract
Risk factors for pathologically confirmed uterine leiomyomas (fibroids) were investigated using data from the Oxford Family Planning Association study, a long term follow up study of women using various methods of contraception. For each of 535 women who had had a fibroid an individual control was selected who matched the patient on age, date of entry into the cohort, and family planning clinic at recruitment and who was alive (and still being followed up) at the date the patient underwent surgery for fibroids. Case-control analysis showed that reproductive experiences were closely linked to development of fibroids. Risk of fibroids decreased consistently with increasing number of term pregnancies; women with five term pregnancies had only a quarter of the risk of women who had had none. Risk also decreased consistently with increasing duration of oral contraceptive use; the risk of fibroids was reduced by some 31% in women who had used oral contraceptives for 10 years. Risk was strongly related to weight: women who weighed under 55 kg had a particularly low risk, and overall the risk rose roughly 21% for each 10 kg increase. Cigarette smoking was associated with a decreased risk of fibroids; smokers of 20 cigarettes a day had a risk roughly two thirds that of non-smokers. These risk factors have all previously been identified as risk factors for endometrial cancer; this strongly suggests that the underlying risk factor is "unopposed" oestrogen.
Similar articles
-
Use of oral contraceptives and uterine fibroids: results from a case-control study.Br J Obstet Gynaecol. 1999 Aug;106(8):857-60. doi: 10.1111/j.1471-0528.1999.tb08409.x. Br J Obstet Gynaecol. 1999. PMID: 10453838
-
A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.Fertil Steril. 1998 Sep;70(3):432-9. doi: 10.1016/s0015-0282(98)00208-8. Fertil Steril. 1998. PMID: 9757871
-
Oral contraceptive use and risk of uterine fibroids.Obstet Gynecol. 1992 Mar;79(3):430-3. doi: 10.1097/00006250-199203000-00021. Obstet Gynecol. 1992. PMID: 1738528
-
Oral contraceptives and life expectancy.Stud Fam Plann. 1986 May-Jun;17(3):117-25. Stud Fam Plann. 1986. PMID: 3523849 Review.
-
Therapeutic management of uterine fibroid tumors: updated French guidelines.Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):156-64. doi: 10.1016/j.ejogrb.2012.07.030. Epub 2012 Aug 29. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22939241 Review.
Cited by
-
Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.BMC Womens Health. 2012 Mar 26;12:6. doi: 10.1186/1472-6874-12-6. BMC Womens Health. 2012. PMID: 22448610 Free PMC article.
-
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.Fertil Steril. 2008 Oct;90(4):911-40. doi: 10.1016/j.fertnstert.2008.08.067. Fertil Steril. 2008. PMID: 18929049 Free PMC article. Review.
-
Racial differences in women who have a hysterectomy for benign conditions.Womens Health Issues. 2009 May-Jun;19(3):202-10. doi: 10.1016/j.whi.2009.03.001. Womens Health Issues. 2009. PMID: 19447324 Free PMC article.
-
Leu/Val SNP polymorphism of CYP1B1 and risk of uterine leiomyoma in a Black population.Tumour Biol. 2016 Mar;37(3):4035-40. doi: 10.1007/s13277-015-4239-8. Epub 2015 Oct 20. Tumour Biol. 2016. PMID: 26482777
-
Evidence that geographic variation in genetic ancestry associates with uterine fibroids.Hum Genet. 2021 Oct;140(10):1433-1440. doi: 10.1007/s00439-021-02322-y. Epub 2021 Jul 23. Hum Genet. 2021. PMID: 34302236 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical